FGD3 mediates lytic cell death, enhancing efficacy and immunogenicity of chemotherapy agents in breast cancer
2025 · Journal of Experimental & Clinical Cancer Research · 0 citations
https://doi.org/10.1186/s13046-025-03559-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
254
Citations
5
h-index
5
i10-index
Xinyi Dai is an academic researcher from University of Illinois Urbana-Champaign. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Impact on Reproduction & Ion Channels and Receptors. The author has an h-index of 5, co-authored 46 publications.
ORCID: 0009-0007-8616-2893Click to start Chat